The current status of cardiac resynchronisation therapy for heart failure

Mattia Arrigo, Mattia Arrigo, Nicolas Vodovar, Nicolas Vodovar, Hélène Nougué, Hélène Nougué, Malha Sadoune, Malha Sadoune, Chris Frampton, Chris Frampton, P Ballan, P Ballan, Pierre‐Olivier Ludes, Pierre‐Olivier Ludes, Nicolas Gendron, Nicolas Gendron, Alain Carpentier, Alain Carpentier, Bernard Cholley, Bernard Cholley, Philippe Bizouarn, Philippe Bizouarn, Alain Cohen‐Solal, Alain Cohen‐Solal, Jagmeet P. Singh, Jagmeet P. Singh, Jackie Szymonifka, Jackie Szymonifka, Christian Latrémouille, Christian Latrémouille, Jane‐Lise Samuel, Jane‐Lise Samuel, Jean‐Marie Launay, Jean‐Marie Launay, Julien Pottecher, Julien Pottecher, Mark Richards, Mark Richards, Quynh A. Truong, Quynh A. Truong, David M. Smadja, David M. Smadja, Alexandre Mebazaa, Alexandre Mebazaa

Article2007

Anticoagulants in heart disease: current status and perspectives

Raffaele De Caterina, Steen Husted, Lars Wallentin, Giancarlo Agnelli, F Bachmann, Colin Baigent, Jørgen Jespersen, Salome Kristensen, Gilles Montalescot, Agneta Siegbahn, Freek W.A. Verheugt, Jeffrey I. Weitz

Article2022

Fifteen-Year Differences in Indications for Cardiac Resynchronization Therapy in International Guidelines—Insights from the Heart Failure Registries of the European Society of Cardiology

Agata Tymińska, Krzysztof Ozierański, Emil Brociek, Agnieszka Kapłon‐Cieślicka, Paweł Balsam, Michał Marchel, María G. Crespo‐Leiro, Aldo Maggioni, Jarosław Dróżdż, Grzegorz Opolski, Marcin Grabowski